Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024498 · ClinicalTrials.gov registry record · NA
Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
A NA study, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 3,492
- Enrollment target
NCT07024498: Recruiting NA study, sponsored by University of California, Davis.
NCT07024498 is a NA study that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 3,492 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07024498, a NA study, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,492 participants
- Enrollment target
Study Summary
The main purpose of this stepped wedge trial will be to test the impact of a bundle of implementation strategies designed to improve ED-outpatient care coordination on long-term buprenorphine retention among adult patients who start buprenorphine for opioid use disorder in a hospital emergency department (ED) and then are referred for continued outpatient buprenorphine treatment after they leave the ED. Our hypothesis is that adopting the bundle of implementation strategies will be associated with subsequent increases in: A) Cumulative number of days with active buprenorphine prescription at 3, 6, and 12 months after patients' initial ED visit (6 months = primary outcome) B) Proportion of patients with active buprenorphine prescriptions without gaps in buprenorphine coverage of more than 7 days at 3, 6, and 12 months after patients' initial ED visit C) Proportion of patients who fill at least 1 outpatient buprenorphine prescription within 30 days of their ED visit D) Clinician reported quality of ED-outpatient care coordination and care transitions
Primary Outcome
Cumulative number of days with active buprenorphine prescription after initial ED visit
Interventions
- OTHER care coordination implementation strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,492 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
What NCT07024498 shows while recruiting
NCT07024498 is an interventional study that assigns participants to a tested intervention. Its 3,492 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher).
The record links to 0 conditions, and to 1 intervention - of which care coordination implementation strategies is the first listed.
NCT07024498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07024498 about?
NCT07024498 is a clinical study titled "Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment". The main purpose of this stepped wedge trial will be to test the impact of a bundle of implementation strategies designed to improve ED-outpatient care coordination on long-term buprenorphine retention among adult patients who start buprenorphine for opioid use disorder in a hospital emergency depar...
What is the current status of trial NCT07024498?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,492 participants. The study started on 2025-11-01. Estimated completion is 2029-08-01.
What interventions are being tested in trial NCT07024498?
The interventions under investigation include: care coordination implementation strategies (OTHER).
Who is sponsoring clinical trial NCT07024498?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07024498's enrollment target sits among peer trials
3,492 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI